期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

CerbB-2、P53的表达与乳腺癌淋巴结转移的关系 被引量：1

原文传递
导出
摘要 目的探讨乳腺癌组织CerbB-2、P53癌基因蛋白表达与淋巴结转移的相关性。方法采用乳腺组织免疫组化SP法检测75例乳腺癌患者中P53及CerbB-2的表达，并分析其临床意义。结果CerbB-2、P53的阳性表达与腋窝淋巴结转移有相关性（P〈0．05）。CerbB-2、P53同阳性与腋窝淋巴结转移相关（P〈0．05）。结论CerbB-2、P53的检测对乳腺癌治疗方案的制定和预后有重要临床意义。
作者 朱红成 闫丰 李明 赵光明
机构地区 华北煤炭医学院附属医院肿瘤外科
出处 《医学新知》 CAS 2010年第3期148-149,共2页 New Medicine
关键词 乳腺癌 腋窝淋巴结转移 免疫组织化 CERBB-2 P53
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献8

  • 1Slamon D J,Clark G M,Wong S G,et al.Human breast cancer:cor-relation of relapse and survival with amp lification of the HER-2/neu oncogene[J].Science,1987,235(4785):177-182.
  • 2Nabholtz J M,Reese D M,Lindsay M A,et al.HER-2 positive breast cancer:update on breast cancer international research group trials[J].Clin Breast Cancer,2002,3(2):75-79.
  • 3Lesley A S,Timothy L L,Jerome E S,et al.Trip-negative breast cancers are increased in black women regardless of age or body mass index[J].Breast Cancer Res,2009,11(2):18-25.
  • 4Ariga R,Zarif A,Kaxasick J,et al.Correlation of Her-2/neugeneamp lification with other prognostic and predictive factors in female breast carcinoma[J].Breast J,2005,11 (4):278-280.
  • 5Nayak B K,Das B R.Mutation and methylation status of p53 gene promoter in human breast tumours[J].Tumor Biol,1999,20(6):340-348.
  • 6Rohan T E,Li S Q,Hartwick R,et al.p53 alterations and protein accmulation in benign breast tissue and breast cancer risk:a cohort study[J].Cancer Epidemiol Biomarkers Prev,2006,15(7):1316-1323.
  • 7Bull S B,Ozcelik H,Pinnaduwage D,et al.The combination of P53 mutation and neu/cerbB-2 amplification is associated with poor survival in node-negative breast cancer[J].J Clin Oncol,2004,22(1):86-96.
  • 8Kroger N,Milde-Langosch K.Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients[J].Clin Cancer Res,2006,12(1):159-168.

同被引文献14

  • 1Chang YW,Kwon KH, Choi DL,et al. Magnetic Resonance Imaging of Breast Cancer and Correlation with Prognostic Factors. Acta Radi- ol, 2009, 990.
  • 2Park SH, Moon WK, Cho N,et al. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology, 2010,257:56.
  • 3Szabo BK, Aspelin P, Wiberg MK, et al. Invasive breast cancer: core- lation of dynamic MR features with prognostic factors. Eur Radiol, 2003,13:2425.
  • 4Slamon D J, Clark GM, Wong SG, et al. Human breast cancer: correla- tion of relapse and survival with amp lification of the HER-2/neu on- cogene. Science, 1987,235 : 177.
  • 5Nabhohz JM , Reese DM, Lindsay MA, et al. HER-2 positive breast cancer:update on breast cancer intemational research group trials. Clin Breast Cancer,2002,3:75.
  • 6Paik S, Bryant J, Park C, et al. CerbB-2 and" response to doxorubicin in patients with axillary lymph node positive, hormone receptor nega- tive breast cancer. J Natl Cancer Inst,1998 ,90 :1361.
  • 7Weigelt B, Peterse JL, vant Veer LJ. Breast cancer metastasis: markers and models. Nat ReyCancer, 2005, 5:591.
  • 8Broet P, Spyratos F, Romain S, et al. Prognostic value of uPA and P53 accumulation measured by quantitative biochemical assays in primary breast cancer patients: a multicentre study. Br Cancer, 1999,80:536.
  • 9Rohan TE, Li SQ, Hartwick R, et al. P53 Alterations and protein ac- cumulation in benign breast tissue and breast cancer risk:a cohort study. Cancer Epidemiol Biomarkers ,2006,15 : 1316.
  • 10Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of con- trast enhancement in breast tumors. J Magn Resort Imaging, 1999, 10:260.

引证文献1

医学新知
2010年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部